Guidance

How medicines, medical devices and clinical trials would be regulated if there’s no Brexit deal

Continuing human medicine, device and clinical trial regulation in the UK if we leave the EU with ‘no deal’.

Documents

Details

If the UK leaves the EU in March 2019 with ‘no deal’, this would affect the regulation of:

  • medicines
  • medical devices
  • clinical trials

We have published an updated guidance note, which is in response to a consultation on a no-deal scenario.

Published 23 August 2018
Last updated 3 January 2019 + show all updates
  1. Updated with a link to an updated guidance note, published in response to a consultation on a no-deal scenario.
  2. Updated to inform that the notices may sometimes apply to businesses and citizens in the EEA.
  3. First published.